These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 20383549)

  • 1. Serious musculoskeletal infections in children receiving anti-tumor necrosis factor-alpha therapy: a case series.
    Morishita K; Petty R; Cairns R; Bolaria R; Cabral D; Turvey S
    Clin Rheumatol; 2010 Jun; 29(6):677-81. PubMed ID: 20383549
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Infection and musculoskeletal conditions: Bacterial and opportunistic infections during anti-TNF therapy.
    Strangfeld A; Listing J
    Best Pract Res Clin Rheumatol; 2006 Dec; 20(6):1181-95. PubMed ID: 17127203
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serious bacterial infections in patients with rheumatoid arthritis under anti-TNF-alpha therapy.
    Kroesen S; Widmer AF; Tyndall A; Hasler P
    Rheumatology (Oxford); 2003 May; 42(5):617-21. PubMed ID: 12709536
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The infectious profiles of anti-tumor necrosis factor agents in a Thai population: a retrospective study a the university-based hospital.
    Suwannalai P; Auethavekiat P; Udomsubpayakul U; Janvitayanujit S
    Int J Rheum Dis; 2009 Jul; 12(2):118-24. PubMed ID: 20374328
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serious Adverse Events Associated with Anti-Tumor Necrosis Factor Alpha Agents in Pediatric-Onset Inflammatory Bowel Disease and Juvenile Idiopathic Arthritis in A Real-Life Setting.
    Pastore S; Naviglio S; Canuto A; Lepore L; Martelossi S; Ventura A; Taddio A
    Paediatr Drugs; 2018 Apr; 20(2):165-171. PubMed ID: 29214394
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rates of serious infection, including site-specific and bacterial intracellular infection, in rheumatoid arthritis patients receiving anti-tumor necrosis factor therapy: results from the British Society for Rheumatology Biologics Register.
    Dixon WG; Watson K; Lunt M; Hyrich KL; Silman AJ; Symmons DP;
    Arthritis Rheum; 2006 Aug; 54(8):2368-76. PubMed ID: 16868999
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Biologic therapies for juvenile arthritis.
    Wilkinson N; Jackson G; Gardner-Medwin J
    Arch Dis Child; 2003 Mar; 88(3):186-91. PubMed ID: 12598373
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Safety of anti-TNFalpha therapy in children with juvenile idiopathic arthritis.
    Dekker L; Armbrust W; Rademaker CM; Prakken B; Kuis W; Wulffraat NM
    Clin Exp Rheumatol; 2004; 22(2):252-8. PubMed ID: 15083897
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Infections in children and adolescents with juvenile idiopathic arthritis and inflammatory bowel disease treated with tumor necrosis factor-α inhibitors: systematic review of the literature.
    Toussi SS; Pan N; Walters HM; Walsh TJ
    Clin Infect Dis; 2013 Nov; 57(9):1318-30. PubMed ID: 23899685
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Focus on adverse events of tumour necrosis factor alpha blockade in juvenile idiopathic arthritis in an open monocentric long-term prospective study of 163 patients.
    Gerloni V; Pontikaki I; Gattinara M; Fantini F
    Ann Rheum Dis; 2008 Aug; 67(8):1145-52. PubMed ID: 17981916
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Therapeutic effects of the anti-tumor necrosis factor monoclonal antibody, infliximab, in four children with refractory juvenile idiopathic arthritis.
    Norambuena R X; Mallol J; Ríos M G; Quevedo R F; Quezada L A
    Allergol Immunopathol (Madr); 2007; 35(2):52-6. PubMed ID: 17428400
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Infliximab or etanercept in the treatment of children with refractory juvenile idiopathic arthritis: an open label study.
    Lahdenne P; Vähäsalo P; Honkanen V
    Ann Rheum Dis; 2003 Mar; 62(3):245-7. PubMed ID: 12594111
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Risk of Tuberculosis in Children with Juvenile Idiopathic Arthritis: A Nationwide Population-Based Study in Taiwan.
    Hsin YC; Zhuang LZ; Yeh KW; Chang CW; Horng JT; Huang JL
    PLoS One; 2015; 10(6):e0128768. PubMed ID: 26047099
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Recent advances in the use of Anti-TNFα therapy for the treatment of juvenile idiopathic arthritis.
    Taddio A; Cattalini M; Simonini G; Cimaz R
    Expert Rev Clin Immunol; 2016 Jun; 12(6):641-9. PubMed ID: 26809126
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of anti-TNF treatment on growth in severe juvenile idiopathic arthritis.
    Tynjälä P; Lahdenne P; Vähäsalo P; Kautiainen H; Honkanen V
    Ann Rheum Dis; 2006 Aug; 65(8):1044-9. PubMed ID: 16449314
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Biological therapy with TNF-inhibitors in pediatric rheumatology. Review of the literature and personal experience].
    Gerloni V; Pontikaki I; Gattinara M; Fantini F
    Reumatismo; 2007; 59(3):244-61. PubMed ID: 17898886
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Short and long-term immunogenicity and safety following the 23-valent polysaccharide pneumococcal vaccine in juvenile idiopathic arthritis patients under conventional DMARDs with or without anti-TNF therapy.
    Aikawa NE; França IL; Ribeiro AC; Sallum AM; Bonfa E; Silva CA
    Vaccine; 2015 Jan; 33(5):604-9. PubMed ID: 25554240
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Risk of herpes zoster in patients with rheumatoid arthritis treated with anti-TNF-alpha agents.
    Strangfeld A; Listing J; Herzer P; Liebhaber A; Rockwitz K; Richter C; Zink A
    JAMA; 2009 Feb; 301(7):737-44. PubMed ID: 19224750
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Infectious complications in juvenile idiopathic arthritis.
    Hurd A; Beukelman T
    Curr Rheumatol Rep; 2013 May; 15(5):327. PubMed ID: 23529583
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serious infections under treatment with TNF-alpha antagonists compared to traditional DMARDs in patients with rheumatoid arthritis.
    Inanc N; Direskeneli H
    Rheumatol Int; 2006 Nov; 27(1):67-71. PubMed ID: 16896990
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.